Skip to content

Evaluation of the aftercare strategy 'New Credo' in a sample of patients with COPD

Evaluation of the aftercare strategy 'New Credo' in a sample of patients with COPD - Credo-COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011652
Enrollment
230
Registered
2017-01-26
Start date
2017-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD A-B-C-D (Global Initiative for Chronic Obstructive Lung Disease) J44

Interventions

Group 1: control group: standard rehab and standard aftercare Group 2: intervention group: increase of physical activity

Sponsors

Forschungsgesellschaft Atemwegerkrankungen e.V.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: COPD A-B-C-D (Global Initiative for Chronic Obstructive Lung Disease), Age 18 to 65 years

Exclusion criteria

Exclusion criteria: diagnosis not secured, rehab discontinued, not able to perfom physical activity, no consent to participate in the study

Design outcomes

Primary

MeasureTime frame
participation (Index for measuring limitations of participation, IMET), at beginning of rehab and after 12 month

Secondary

MeasureTime frame
subjective health (questionnaire) at beginning of rehab, after rehab and after 12 month

Countries

Germany

Contacts

Public ContactRuth Deck

Institut für Sozialmedizin und Epidemiologie, Universität Lübeck

ruth.deck@uksh.de0451 50051211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026